Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tectonic Therapeutic (TECX) Common Equity (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Common Equity data on record, last reported at $230.4 million in Q1 2026.

  • On a quarterly basis, Common Equity fell 23.46% to $230.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $230.4 million, a 23.46% decrease, with the full-year FY2025 number at $251.3 million, up 78.53% from a year prior.
  • Common Equity reached $230.4 million in Q1 2026 per TECX's latest filing, down from $251.3 million in the prior quarter.
  • Over the last five years, Common Equity for TECX hit a ceiling of $301.0 million in Q1 2025 and a floor of -$99.6 million in Q1 2024.
  • A 5-year average of $100.7 million and a median of $140.8 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: tumbled 181.33% in 2023, then soared 402.32% in 2025.
  • Tracing TECX's Common Equity over 5 years: stood at -$45.7 million in 2022, then plummeted by 85.39% to -$84.6 million in 2023, then soared by 266.33% to $140.8 million in 2024, then soared by 78.53% to $251.3 million in 2025, then dropped by 8.32% to $230.4 million in 2026.
  • Business Quant data shows Common Equity for TECX at $230.4 million in Q1 2026, $251.3 million in Q4 2025, and $267.5 million in Q3 2025.